Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy

Shi, V.J.; Rodic, N.; Gettinger, S.; Leventhal, J.S.; Neckman, J.P.; Girardi, M.; Bosenberg, M.; Choi, J.N.

JAMA Dermatology 152(10): 1128-1136

2016

2168-6068

10.1001/jamadermatol.2016.2226

https://eurekamag.com/research/057/418/057418470.php